Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | |
Div Cover | n/a | |
Op Mrgn | 1.4% | |
ROCE | 9.8% |
Latest | F'cast | |
---|---|---|
P/E | 547.3 | |
PEG | n/a | |
Pr/Revenue | 4.0 | |
Pr/Book | 4.9 |
Latest | F'cast | |
---|---|---|
Revenue | 14.8% | |
PBT | -62.0% | |
EPS | -94.0% | |
DPS | n/a |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 2,666.70 | (232.22) | (136.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 2,986.27 | 570.44 | 430.00¢ | 17.1 | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 3,394.64 | 529.12 | 153.00¢ | 52.5 | n/a | -64% | n/a | 0.0% |
31-Dec-23 | 3,695.65 | 834.22 | 267.00¢ | 23.5 | 0.3 | +74% | n/a | 0.0% |
31-Dec-24 | 4,241.22 | 316.63 | 16.00¢ | 431.7 | n/a | -94% | n/a | 0.0% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 4,840.17 | 1,489.92 | 619.94¢ | 14.1 | 0.0 | +3,775% | n/a | 0.0% |
31-Dec-26 | 5,365.10 | 1,830.03 | 724.37¢ | 12.1 | 0.7 | +17% | n/a | 0.0% |
31-Dec-27 | 5,858.77 | 2,220.39 | 871.96¢ | 10.0 | 0.5 | +20% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
FDA grants EUA for Eli Lilly treatment in conjun... | 20-Nov-2020 | ShareCast |
Currency | US Dollars |
Share Price | $ 87.57 |
Change Today | $ 0.26 |
% Change | 0.30 % |
52 Week High | $88.54 |
52 Week Low | $55.11 |
Volume | 2,070,856 |
Shares Issued | 193.43m |
Market Cap | $16,939m |
RiskGrade | 196 |
Strong Buy | 6 |
Buy | 4 |
Neutral | 12 |
Sell | 2 |
Strong Sell | 0 |
Total | 24 |
Time | Volume / Share Price |
16:00 | 487,812 @ $87.57 |
15:59 | 260 @ $87.56 |
15:59 | 230 @ $87.56 |
15:59 | 100 @ $87.55 |
15:59 | 100 @ $87.55 |
You are here: research